Risks in the Drug Procurement System

Current Issues

Bibliographic Data

ID5721429
AuthorsNatalia Prodanova (0000-0001-5140-2702, Plekhanov Russian University of Economics), Natalia Alekseevna Prodanova, Usman Salmanovich Zhaubatyrov (Astrakhan State Medical University), Elena Ivanovna Zatsarinnaya, Еlena I Zatsarinnaya (Plekhanov Russian University of Economics), Vitaly V Goncharov (0000-0003-3029-4727, Kuban State Agrarian University), Nadezda Sergeevna Elizarova Elizarova (Moscow Polytechnic University), Nadezda Sergeevna Elizarova, Stepan Anatol''Evich Buryakov, Stepan Anatol'Evich Buryakov (Institute of Service and Entrepreneurship of DGTU)
Year2021
Volume9
IssueSPE3
Publication date2021-01-01
Peer ReviewedYes
Open AccessYes
TypeARTICLE
VenuePropósitos y Representaciones (JOURNAL)
Journal identifiersISSN: 2307-7999 • E-ISSN: 2310-4635
PublisherUniversidad San Ignacio de Loyola S.A (PUBLISHER)
DOI10.20511/pyr2021.v9nspe3.1144
OpenAlexW3139261771
LanguageEN

The public procurement segment is one of the components of the pharmaceutical market in Russia. Procurement of medicines and medical devices is the top sector of public procurement, both in terms of their number and the amount of contracts concluded. The procedure for concluding state contracts itself is spelled out in sufficient detail in the regulatory documents, but, despite this, risks may arise when concluding a state contract both for a potential applicant for a state order and for a state customer. The purpose of the study is to determine the possible risks when concluding a state contract of a healthcare institution for medicines and medical devices and ways to reduce them

Business · Industrial organization · Institution · Medical device · Political science · Procurement · Computer Science · Economic Sanctions and International Relations · Economic, Social, and Public Health Issues in Russia and Globally · Law · Medicine · Pharmaceutical Economics and Policy · Finance · Marketing

Tools

Open DOIOpen Access